Related by context. All words. (Click for frequent words.) 59 oral clodronate 59 anthracycline taxane 58 taxane chemotherapy 58 advanced HER2 positive 58 taxane chemotherapy administered 57 subcutaneous enoxaparin 57 #mg ATC 57 treating chronic myeloid 57 Gleevec imatinib 57 mitoxantrone plus 56 drug PTK ZK 56 mastectomy chemotherapy 56 tamoxifen therapy 56 underwent liver transplantation 56 non mutated KRAS 56 detectable HCV RNA 56 rediagnosed 56 systemic ALCL 56 maximally tolerated lipid lowering 56 Tocosol Paclitaxel 56 cancerous nodules 56 overexpress HER2 55 Roche Herceptin 55 untreated metastatic pancreatic 55 MS relapses 55 neoadjuvant setting 55 refractory myeloma 55 ZOLINZA 55 antiestrogen therapy 55 BRCA deficient 54 indolent follicular non 54 Riluzole 54 lenalidomide Revlimid R 54 non hodgkin lymphoma 54 Femara letrozole 54 Alimta pemetrexed 54 immunosuppressive medication 54 Crizotinib 54 Jevtana 54 chemosensitizer 54 induce remission 54 ImClone Erbitux 54 humanised monoclonal antibody 54 cancerous polyp 54 intraperitoneal therapy 54 Cabazitaxel 54 Tumors shrank 54 Gleevac 54 unexplained vaginal bleeding 54 achieved CCyR 54 Taxol paclitaxel 54 metastatic lung cancer 53 drug Treanda 53 colorectal cancer liver metastases 53 metastatic kidney 53 interferon ribavirin 53 recurrent metastatic 53 chemo therapy 53 Novartis AG Gleevec 53 undergone hysterectomy 53 pegylated interferon peg IFN 53 steroid prednisone 53 adalimumab Humira 53 ferroportin levels 53 pamidronate 53 prior chemotherapy regimens 53 untreated metastatic colorectal 53 transplanted islets 53 paclitaxel Taxol R 53 anthracyclines taxanes 53 docetaxel chemotherapy 53 Adjuvant chemotherapy 53 Cholesterol lowering statins 53 resistant hormone refractory 53 drug Mylotarg 53 Sprycel dasatinib 53 undergoing hysterectomy 53 vinflunine 53 cetuximab Erbitux 52 operable breast cancer 52 paclitaxel cisplatin 52 renal flares 52 Gemzar gemcitabine 52 metastatic bladder 52 induced anemia 52 metastasized breast cancer 52 patient derived xenografts 52 OvaRex 52 iniparib 52 AGILECT R 52 docetaxel Taxotere 52 type 1diabetes 52 intra arterial chemotherapy 52 previously untreated follicular 52 NSABP C 52 anti coagulant drugs 52 Theratope 52 neurologic progression 52 KRAS mutant tumors 52 Bezielle 52 demonstrated antitumor activity 52 metastatic renal cell 52 Clot busting 52 motesanib 52 relapsed MM 52 antithymocyte globulin 52 Alessandro Riva 52 cytotoxic therapy 52 metastatic colorectal 52 ASAQ combines 52 clodronate 52 radiation chemoradiation 52 Arranon 51 unresectable tumors 51 Liposomal Grb 2 51 drug Recentin 51 wife Ethie 51 underwent hysterectomy 51 diseases Cerezyme 51 Gleevec 51 EGFR mutation positive 51 complete cytogenetic response 51 EGFR TKI 51 refractory colorectal cancer 51 allogeneic HSCT 51 peritoneal cancer 51 anthracycline containing 51 cytoreduction 51 cediranib 51 Cytoxan 51 taxane refractory 51 progression TTP 51 TransVax 51 KRAS mutations occur 51 PTK# 51 leukemia AML 51 stage IIIB IV 51 biochemical relapse 51 perioperatively 51 sickest colon cancer 51 ovarian cervical 51 Temodar ® 51 Paraplatin 51 TNF alpha antagonist 51 nonsmall cell lung cancer 51 ASONEP ™ 51 bi lateral mastectomy 51 tamoxifen Nolvadex ® 51 intravenous cyclophosphamide 51 midstage clinical 51 rindopepimut 51 FUSILEV enhances 51 FOLFOX chemotherapy 51 drug figitumumab 51 diag nosed 51 relapsing remitting MS RRMS 51 myeloablative 51 achieved ACR# 51 lymphomas leukemias 51 antiandrogen 51 CMV infections 51 mycophenolate 51 expressing metastatic colorectal 51 bone marrow reticulin deposition 51 inhibiting telomerase 51 immune suppressant 51 decompensated cirrhosis 51 tumors GIST 51 progressed Arauco 51 metastatic gastric 51 prescribe cholesterol lowering 51 undergoing chemo 51 ABRAXANE therapy 51 Enbrel arthritis 51 shingles herpes zoster 51 concurrent chemoradiation 51 Glioblastoma Multiforme 51 paclitaxel chemotherapy 51 de novo kidney transplant 51 surgical debulking 51 class mGluR5 inhibitor 51 TTF Therapy 51 Axitinib 51 swollen lymph node 51 basiliximab 51 5-fluorouracil/leucovorin 51 nonsquamous 51 Tolamba 51 chemo resistant 51 gastrointestinal stromal tumor GIST 51 acute STEMI 51 blastic phase 51 precancerous condition 50 paclitaxel Taxol ® 50 Enbrel rheumatoid arthritis 50 sulfonylurea metformin 50 durable remissions 50 bone marrow biopsies 50 lymphocytic leukemia 50 cisplatin resistant 50 Depo Provera injections 50 neutropenic sepsis 50 receiving XGEVA 50 semagacestat 50 Erbitux cetuximab 50 ovarian endometrial 50 imatinib Gleevec 50 metastatic adenocarcinoma 50 autologous transplant 50 Neuvenge 50 BRAF inhibitor 50 drug Temodar 50 premalignant lesion 50 refractory indolent non 50 detecting precancerous 50 chemotherapy Xeloda 50 recurrent bladder 50 calcineurin inhibitor 50 adjuvant colon cancer 50 rolofylline 50 pilocytic astrocytoma 50 Bayer Nexavar 50 solanezumab 50 thyroid hormone replacement 50 HER2 positive breast 50 Ception Therapeutics Inc. 50 operable basal cell carcinoma 50 immunosuppressant medications 50 drug DMARD 50 undetectable virus HCV 50 Ontak 50 mutated K ras 50 non resectable metastatic 50 OSI Tarceva 50 reimplanted 50 prescribed blood thinners 50 asthma rheumatoid arthritis 50 corticosteroid dexamethasone 50 non myeloid malignancies 50 recurrent Hodgkin 50 cardiotoxic 50 autoantibody positive 50 refractory chronic myeloid 50 baminercept 50 patients receiving myelosuppressive 50 mother Margrid 50 uterine fibroid induced 50 Hodgkin lymphoma HL 50 advanced epithelial ovarian 50 undergo mastectomy 50 midstage trials 50 Lucrin 50 Amgen Neulasta ® 50 androgen suppression therapy 50 curable cancers 50 lapatinib Tykerb 50 decompensated liver disease 50 Ph + acute lymphoblastic 50 Chronic Myelogenous Leukemia CML 50 Thal Dex 50 cyclophosphamide chemotherapy 50 recurrent epithelial ovarian 50 relapsed acute lymphoblastic 50 HAART regimen 50 Temsirolimus 50 abiraterone 50 obstructed bile duct 50 immune suppressing 50 bladder ovarian 50 Campath alemtuzumab 50 immunosuppressant drug 50 Pulminiq 50 bile duct cancers 50 underwent resection 50 thalidomide Thalomid 50 irinotecan chemotherapy 50 Caelyx 50 chemotherapy 50 cranial radiation 50 levosimendan 50 dexanabinol 50 relapsed leukemia 49 stage IIIb IV 49 daily subcutaneous injections 49 adriamycin 49 thrice weekly dialysis 49 Merck KGaA Erbitux 49 refractory acute lymphoblastic 49 undergone lumpectomy 49 HER2 negative 49 mutated KRAS 49 advanced nonsquamous NSCLC 49 recurrent atrial fibrillation 49 following antiestrogen therapy 49 HERCEPTIN 49 cyclophosphamide AC 49 chronic lymphatic leukemia 49 Median survival 49 clomipramine 49 compound INCB# 49 metastatic testicular cancer 49 Anthracycline 49 Chronic lymphocytic leukemia CLL 49 interferon therapy 49 Symbicort asthma 49 cabazitaxel 49 recurred 49 cisplatin chemotherapy 49 alkylating agent 49 Artificial pancreas 49 prednisone steroid 49 Raptiva efalizumab 49 fluvastatin 49 relapsed GBM 49 endostatin 49 aromatase inhibitor therapy 49 anagrelide 49 drank pomegranate juice 49 eflornithine 49 underwent chemotherapy 49 olaparib 49 inhibit platelet function 49 FOLFOX4 49 imatinib therapy 49 impair fertility 49 Sudhir Agrawal D.Phil 49 lumpectomy chemotherapy 49 HER2 positive tumors 49 lobular cancer 49 FOLFIRI alone 49 Torisel 49 mutant KRAS 49 Sutent sunitinib 49 esthesioneuroblastoma rare form 49 midstage clinical trials 49 Untreated mice 49 flutamide 49 thymic carcinoma 49 herceptin 49 paroxysmal AF 49 chemotherapy cisplatin 49 cancerous colon polyps 49 Tykerb lapatinib 49 raloxifene Evista 49 nadroparin 49 Revlimid lenalidomide 49 vaccine Stimuvax 49 exemestane Aromasin 49 Herceptin trastuzumab 49 Lucentis injections 49 underwent surgical resection 49 undergone mastectomy 49 Commonly prescribed 49 Panamanian cough syrup 49 gastrointestinal stromal tumors GIST 49 Folfox 49 abnormal uterine growths 49 uterine fibroid tumors 49 TNF antagonist 49 Tarvacin Anti Cancer 49 pemphigus vulgaris 49 non Hodgkins Lymphoma 49 hormone refractory 49 pancreatic neuroendocrine tumor 49 MyVax R 49 leukemia ALL 49 docetaxel Taxotere ® 49 lumiliximab 49 ovulatory cycles 49 blood clot preventer 49 benign nodules 49 letrozole Femara 49 Exubera inhaled insulin 49 XL# administered orally 49 TKI therapy 49 Aromasin 49 BARACLUDE ® 49 superficial bladder cancer 49 taxotere 49 radiotherapy chemotherapy 49 Tarceva TM 49 locoregional recurrence 49 cells multiply uncontrollably 49 aprepitant 49 Glioblastoma Multiforme GBM 49 nonmetastatic 49 oral ridaforolimus 49 castrate resistant 49 transfusion syndrome 49 azilsartan medoxomil 49 approved incretin mimetic 49 refractory ovarian cancer 49 vaccine Oncophage 49 Ewing sarcoma bone 49 clazosentan 49 adjuvant radiation 49 Sunitinib 49 Gestational diabetes occurs 49 nephrosis 49 Tysabri multiple sclerosis 49 standard chemotherapy regimen 49 heavily pretreated 49 Iressa lung cancer 49 virologically 49 curative therapy 49 acute myelogenous leukemia AML 49 AML acute myeloid 49 LymphoStat B belimumab 49 recurrent myocardial infarction 49 rALLy 49 midstage clinical trial 49 pegfilgrastim 49 oral methylnaltrexone 49 Lung transplantation 49 virologic failure 49 peginterferon alpha 2a 48 Telcyta 48 Valtrex valacyclovir 48 serum calcium levels 48 autologous hematopoietic stem cell 48 antiangiogenic therapy 48 lung metastases 48 isradipine 48 adjuvant cisplatin 48 adefovir 48 Crohns disease 48 PSADT 48 temozolomide Temodar 48 eribulin 48 dermatofibrosarcoma protuberans 48 cytarabine daunorubicin 48 prepaid Allcare 48 alkylating agents 48 recurrent glioblastoma multiforme 48 total abdominal hysterectomy 48 oral antidiabetes 48 LHRH receptor positive 48 oral vancomycin 48 fallopian tube carcinoma 48 Rilutek 48 LymphoStat B TM 48 nilotinib Tasigna ® 48 odanacatib 48 tafamidis 48 Cell Lymphoma CTCL 48 CR nPR 48 rHuEPO 48 molindone 48 prescribing Bextra 48 dyskeratosis congenita 48 Aflibercept 48 DCVax ® Brain 48 methotrexate therapy 48 nasal pharyngeal cancer 48 Carol Huesman 48 uric acid lowering 48 Klitzka 48 prolongs survival 48 chlorambucil 48 Genentech Rituxan 48 Zytiga 48 Hormone pills 48 steroid refractory GvHD 48 Certolizumab pegol 48 PASI scores 48 Cellcept 48 lupus nephritis 48 immune suppressants 48 recurrent glioblastoma multiforme GBM 48 radical mastectomy 48 goserelin 48 antiretroviral naïve 48 anthracycline therapy 48 relapsed ALL 48 relapsed ovarian cancer 48 untreated mice 48 immunosuppressant medication 48 BRAF mutant 48 Stage IIIb 48 imexon 48 advanced unresectable 48 cetuximab Erbitux R 48 Taxol 48 clot dissolving drugs 48 undergoing kidney transplant 48 lymph node biopsy 48 metastatic hormone refractory 48 untreated chronic lymphocytic 48 PLX# 48 Viread Emtriva 48 postoperative chemotherapy 48 Velcade bortezomib 48 chewed sugarless gum 48 unruptured aneurysm 48 MMP inhibitor 48 RET PTC rearrangements 48 diabetic kidney 48 hereditary pancreatitis 48 refractory acute myeloid 48 Nexavar sorafenib 48 iniparib BSI 48 transplanted liver 48 malignant polyp 48 mitoxantrone chemotherapy 48 sustained virologic response 48 myelogenous leukemia 48 Amoxicillin Pulsys 48 radioiodine therapy 48 Epivir 48 MAGE A3 ASCI 48 unresectable stage 48 nucleotide analog 48 bowel resection 48 Xelox 48 Onglyza saxagliptin 48 basal cell skin 48 pegylated interferon alpha 48 Zolinza 48 liver metastases 48 zoledronic acid Zometa 48 osteogenic sarcoma 48 Acute Myeloid Leukaemia 48 Adjuvant therapy 48 Doxil ® 48 androgen ablation 48 receiving antibiotics intravenously 48 Taxotere docetaxel 48 autologous transplants 48 Novartis Afinitor 48 cause mesothelioma asbestosis 48 tumor regrowth 48 visilizumab 48 ® bevacizumab 48 Merck Isentress 48 viral reactivation 48 Hydroxyurea 48 Premarin estrogen 48 sunitinib sorafenib 48 uterus womb 48 defibrillator shocks 48 CD8 + cytotoxic 48 malignant salivary gland 48 Infusion reactions 48 #mg BID [001] 48 losartan Cozaar 48 refractory CML 48 gemcitabine chemotherapy 48 inhibits ovulation 48 metastatic malignant 48 metastatic CRPC 48 ACTEMRA TM 48 diseased liver 48 chemotherapy regimen 48 TDF FTC 48 Paxil paroxetine 48 metastasized melanoma 48 SGS# 48 unresectable recurrent 48 smoldering multiple myeloma 48 postmenopause 48 Flu Cy 48 advanced carcinoid 48 FOLFOX6 48 antibiotic rifaximin 48 prostate cancer HRPC 48 prednisone prednisolone 48 underwent mastectomy 48 IV malignant melanoma 48 smoldering myeloma 48 PROSTVAC VF 48 Inhaled nitric oxide 48 medically inoperable 48 Rituxan rituximab 48 Prostate tumors 48 differentiated thyroid 48 polycystic kidneys 48 refractory NSCLC 47 remission 47 containing abacavir 47 pancreatic neuroendocrine tumors 47 severe aplastic anemia 47 assessing T DM1 47 chronic HCV genotype 47 phase IIb study 47 hormone refractory prostate cancer 47 suppress viral replication 47 erlotinib Tarceva 47 cryosurgery freezing 47 cranial irradiation 47 Novartis AG NVS NOVN.VX 47 selegiline 47 Amgen Vectibix 47 dexamethasone Decadron 47 metastatic colon cancer 47 myelofibrosis MF 47 cetuximab Erbitux ® 47 Interferon beta 1b 47 Topotecan 47 allogenic stem cell 47 irinotecan containing 47 hormonally responsive 47 virological suppression 47 Gleevec imatinib mesylate 47 oral rivaroxaban 47 Annamycin 47 H. pylori eradication 47 measurable tumor regressions 47 Ivanhoe Newswire Patients 47 Bevacizumab Avastin 47 metastatic castration resistant 47 estramustine 47 Stage IIIB IV 47 thienopyridine 47 idiopathic thrombocytopenic purpura ITP 47 pneumocystis carinii pneumonia 47 AstraZeneca Iressa 47 phase III isavuconazole 47 anakinra 47 endometrial hyperplasia 47 prostate cancer metastases 47 acute GvHD 47 precancerous colon growths 47 antiresorptive 47 Canvaxin 47 irinotecan doxorubicin oxaliplatin paclitaxel 47 HNSCC 47 Avastin Tarceva 47 Phase IIb clinical trials 47 GVAX 47 acute gout flares 47 nonhormonal 47 diabetic ulcer 47 forodesine 47 alvespimycin 47 elacytarabine 47 Novantrone 47 posttransplant 47 dialed Ybarra 47 recurrent genital herpes 47 disease modifying antirheumatic 47 Camptosar ® 47 TNF inhibitor 47 mCRC patients 47 GLP1 agonist 47 antirejection 47 fulvestrant 47 MyVax 47 Hepatocellular Carcinoma HCC 47 gefitinib Iressa 47 lung metastasis 47 curative resection 47 radiation enteritis 47 herpes lesions 47 tumor resection 47 intravenous antibiotic therapy 47 chemo 47 undergo chemotherapy 47 Paraplatin ® carboplatin 47 IV bisphosphonates 47 Lapatinib 47 hormone deprivation 47 Elotuzumab 47 Elan Tysabri 47 sorafenib Nexavar 47 trastuzumab Herceptin ® 47 symptom flare ups 47 menopausal symptom 47 progressively sicker 47 Donega 47 synovial cell 47 complete cytogenetic 47 Mary Relling Pharm.D 47 albiglutide 47 investigational oral hepatitis C 47 venlafaxine ER 47 irradiated mice 47 bortezomib Velcade 47 Edwina Moncur 47 gastrointestinal stromal tumor 47 abnormal pap smear 47 interferon beta therapy 47 galiximab 47 prostate cancer CRPC 47 pre cancerous polyps 47 Cinquil 47 Bcr Abl T#I mutation 47 Imuran 47 pertuzumab 47 medulla blastoma 47 intravenous antibiotic 47 refractory SCLC 47 5 fluorouracil leucovorin 47 weekly intravenous infusions 47 TRAIL receptor antibodies 47 standard chemotherapy regimens 47 Specifid 47 drug NP2 Enkephalin 47 epirubicin cyclophosphamide 47 metastatic HER2 positive 47 bortezomib refractory 47 untreated AML 47 Interferon alpha 47 deCODE ProstateCancer TM 47 L dopa 47 REGN# 47 hormone receptor negative 47 CIPN 47 rituximab Rituxan 47 hour bronchodilation 47 cell carcinoma RCC 47 pancreatitis inflammation 47 metastatic renal 47 upon rechallenge 47 dirucotide MBP# 47 recurrent prostate cancer 47 debulking surgery 47 acute lymphoblastic 47 cell enzymes metabolize 47 alveolar rhabdomyosarcoma 47 RSV hospitalizations 47 hormonally sensitive 47 Hurthle cell 47 alefacept 47 idiotype vaccines 47 hormone refractory prostate 47 HER2 positive metastatic 47 bilateral prophylactic mastectomy 47 Wilms tumors 47 GIST tumors 47 imatinib Gleevec ® 47 got Abbott MitraClip 47 inoperable pancreatic cancer 47 basis Josehart 47 ixabepilone 47 Valproic acid 47 VELCADE melphalan 47 radiation therapy SBRT 47 tolterodine 47 mutated KRAS gene 47 Crohn disease bowel 47 anti TNFa 47 systemic anaplastic large 47 preoperative chemotherapy 47 pegylated liposomal doxorubicin 47 exemestane 47 immunomodulatory therapy 47 kidney pancreas transplant 47 gastrointestinal stromal tumors 47 CCyR 47 basal cell cancers 47 ELACYT 47 tumor angiogenesis inhibitors 47 recurrent glioblastoma 47 anticlotting drugs 47 treating neuropathic pain 47 Biogen Genentech 47 Exemestane 47 advanced medullary thyroid 47 myelodysplastic myeloproliferative diseases 47 Azacitidine 47 plus prednisone prednisolone 47 Recentin 47 follicular Non Hodgkin 47 trastuzumab Herceptin R 47 taxane therapy 47 chemo radiotherapy 47 pill Galvus 47 patients undergoing chemotherapy 47 desmoid tumor 47 ovulation inducing 47 Simponi golimumab 47 Degarelix 47 anthracycline chemotherapy 47 AVASTIN 47 briakinumab 47 clopidogrel Plavix 47 Proleukin 47 chemotherapy gemcitabine 47 undergoing peritoneal dialysis 47 Xyotax 47 Seewaldt 47 yearly subcutaneous injections 47 sunitinib Sutent 47 dasatinib Sprycel 47 Genentech Herceptin 47 undergo radical prostatectomy 47 Provenge prostate cancer 47 Taxotere chemotherapy 47 metastatic CRC 47 pediatric malignancies 47 Zactima 47 pancreatic resection 47 mRCC 47 docetaxel prednisone 47 TMEM density 47 Bonefos 47 chronic idiopathic 47 maximal doses 47 PTK ZK 47 pretransplant 47 achieved sustained virological 47 Gleevec resistant 47 Vertex hepatitis C 47 abrupt cessation 47 OncoVAX 47 corticosteroid therapy 46 surgically corrected 46 leflunomide 46 weekly subcutaneous injections 46 commercialize deforolimus 46 oxymorphone ER 46 intermittent dosing 46 severe exacerbations 46 Telintra 46 Onconase 46 lymph node biopsies 46 biliary tract cancer 46 Gabapentin GR TM 46 malignant glioma brain tumor 46 mycophenolate mofetil MMF 46 chemotherapy docetaxel 46 p#HER# positive 46 EVIZON TM 46 Improved Progression 46 reinfused 46 non porcine pancreatic 46 paricalcitol 46 underwent lumpectomy 46 folinic acid 46 UCB Cimzia 46 nilotinib 46 partial hysterectomy 46 indolent NHL 46 blighted poverty stricken 46 minimally symptomatic 46 LY# [003] 46 Ixempra 46 hormonal treatments 46 cyclophosphamide methotrexate 46 non metastatic osteosarcoma 46 mapatumumab 46 Losartan 46 mycophenolate mofetil 46 drugs DMARDs 46 masectomy 46 oral anticancer 46 alpha1 antitrypsin AAT deficiency 46 angiogenesis inhibitor 46 OSI Pharmaceuticals lung cancer 46 hormonal therapies 46 ribavirin therapy 46 pancreatic carcinoma 46 osteochondral allograft 46 stent implanted 46 antiplatelet medication 46 precancerous tumors 46 A1c levels 46 Teriflunomide 46 CMV disease 46 lumbar disk herniation 46 #mg/m# [002] 46 NSCL cancer 46 oxypurinol 46 vismodegib 46 colorectal lung 46 gemcitabine cisplatin 46 refractory Hodgkin 46 FLT3 ITD 46 muscles atrophied 46 CHOP chemotherapy 46 Vorapaxar 46 ponatinib 46 Acute Myelogenous Leukemia 46 antibiotic regimen 46 docetaxel Taxotere R 46 acquire genital HPV 46 chemos 46 neutropenic 46 precancerous spots 46 DONOHUE My 46 thyroid deficiency 46 temozolomide 46 Fosamax alendronate 46 Tarceva erlotinib 46 endometrial carcinoma 46 overt hepatic encephalopathy HE 46 cilengitide 46 EGFR inhibitor therapy 46 benign polyps 46 biologic antibody 46 artery reclogging 46 HER2 expressing 46 treating cancerous tumors 46 Cimzia TM 46 Louis Washkansky 46 penicillin allergy 46 Vidaza azacitidine 46 Waldenstrom macroglobulinemia 46 chemotheraphy 46 induced neuropathy 46 ropinirole 46 intensive statin therapy 46 chronic plaque psoriasis 46 humanized therapeutic 46 Herceptin 46 alpha interferons 46 Chaman Ara 46 HER2 positive breast cancer 46 Mylotarg 46 lymph gland 46 pemetrexed Alimta 46 Dasatinib 46 acid suppressants 46 Jack Linkletter 46 disease progression TTP 46 5q deletion 46 indicate Schnuphase 46 Stereotactic body 46 decitabine 46 CRESTOR rosuvastatin calcium 46 endocrine therapies 46 enzastaurin 46 fibrocystic disease 46 orchidectomy 46 papillary renal cell carcinoma 46 chronic myeloid 46 treating sarcoma testicular 46 Smelling rotting flesh 46 Itopride 46 HIV treatments Reyataz 46 Dendreon Provenge 46 bile duct tumors 46 metastatic pancreatic 46 inoperable tumors 46 Belldegrun 46 mTOR inhibitors 46 genital lesions 46 Diamyd ® 46 immunosuppressive regimen 46 Onrigin 46 Pegasys plus Copegus 46 plasma uric acid 46 stasis ulcers 46 relapsed 46 ovarian lung 46 receiving golimumab 46 recurrent malignant glioma 46 Chronic pancreatitis 46 prescribed beta blocker 46 placebo dexamethasone 46 radiolabeled TM# 46 combination estrogen progestin 46 Sheena Visto 46 bardoxolone methyl 46 partial mastectomy 46 anti CD3 antibody 46 exocrine pancreatic insufficiency EPI 46 small molecule tyrosine 46 tubal ligation reversal 46 perforated colons 46 metastatic ovarian cancer 46 thrombotic complications 46 Yervoy 46 AMN# [001] 46 thrombocytopenic patients 46 FTIs 46 Omnitarg 46 Hurler Syndrome 46 prolonged cytopenias 46 interferon beta 46 Gliadel Wafer 46 doublet chemotherapy 46 palliative radiotherapy 46 CYT# potent vascular disrupting 46 biliary cancer 46 remission induction 46 pulmonary exacerbation 46 underarm lymph nodes 46 recurrent NSCLC 46 bronchopulmonary dysplasia 46 undergone kidney dialysis 46 keloid scarring 46 Myelodysplastic Syndrome MDS 46 conventional DMARDs 46 anti TNFs 46 GnRH agonist 46 precancerous lesion 46 TBC# 46 drug Pulmicort 46 impair cognition 46 squamous histology 46 Votrient 46 doxorubicin cyclophosphamide 46 aflibercept 46 Vincristine 46 advanced metastatic prostate 46 LHRH analogues 46 pancreatic adenocarcinoma 46 Tykerb